The opening of the DIGITAL-2026-AI-PILOTING-10-SCREENING
The opening of the DIGITAL-2026-AI-PILOTING-10-SCREENING call, with a total budget of €9 million, marks a concrete step in Europe’s strategy for artificial intelligence in healthcare: bringing imaging-based solutions directly into clinical settings, with a focus on early detection of cancer and cardiovascular disease — no longer just research, but operational deployment.
The term piloting refers to a specific phase: testing technologies within the real operational workflows of medical centers, evaluating their impact across three key dimensions:
- Integration into clinical workflows in the daily practice of physicians;
- Interoperability with existing systems, assessing compatibility with infrastructure and data already in use (PACS/RIS);
- Operational sustainability at scale, measuring the capacity to handle large volumes over time.
The decision to include oncology and cardiovascular disease within the same framework reflects a clear rationale: these are the two leading causes of mortality in Europe and represent high-volume diagnostic areas, where process efficiency is as critical as clinical accuracy.
In this context, one often-overlooked element stands out: the management of negative exams. In breast cancer screening programs, for example, more than 90% of exams show no signs of cancer. This figure highlights the potential of artificial intelligence in supporting diagnostic triage, reducing the burden on radiologists and improving priority management.
It is precisely on this principle that several AI solutions applied to medical imaging are being developed, with the goal of optimizing clinical workflows and making large-scale screening programs sustainable.
While this approach is already at an advanced stage in oncology, the real challenge will be extending it to other high-volume settings — such as cardiovascular diagnostics — while maintaining comparable standards of reliability and integration.
The question, therefore, is no longer whether artificial intelligence works. It is whether it can be used in a systematic, safe — in compliance with the European Medical Device Regulation (MDR) — and scalable way within healthcare systems. And that is precisely the transition the new European funding calls aim to accelerate.
――――――――――――――――――――
Informational Note
The DIGITAL-2026-AI-PILOTING-10-SCREENING call is open to public and private entities from EU Member States and associated countries. Up to 2 projects may be funded, with a maximum EU contribution of €4.5 million per project and a co-financing rate of 50%, as indicated in the official Digital Europe programme documentation. Deadline: October 1, 2026.
